---
figid: PMC9266688__ijms-23-07359-g008
figtitle: 'Tumor-Suppressor Role of the A1-Na/K-ATPase Signalosome in NASH Related
  Hepatocellular Carcinoma '
organisms:
- NA
pmcid: PMC9266688
filename: ijms-23-07359-g008.jpg
figlink: /pmc/articles/PMC9266688/figure/ijms-23-07359-f008/
number: F8
caption: 'Proposed schematic diagram of activated α1-NKA Signalosome mediated NASH-related
  HCC malignancy. At the onset of NAFLD, the signalosome is inactive but as NAFLD
  progresses there is generation of ROI, resulting in the activation of the signalosome
  and induction of NASH. Continuous activation of the signalosome by ROI, coupled
  with the underlying NASH microenvironment results in the amplification of ROI production
  via the EGFR-Ras/Raf/MEK/ERK cascade, turning into a vicious cycle that intensifies
  the activation of the α1-NKA/Src signalosome which concludes in genesis of liver
  malignancy by survivin overexpression. Survivin induces carcinogenesis by inhibiting
  apoptosis, and heightening cell proliferation and tumor angiogenesis. The chart
  also displays certain proteins and metabolic and morphological disarray that drive
  activated α1-NKA signalosome-mediated hepatocarcinogenesis. (Note: EGFR, Ras/Raf/MEK/ERK
  pathway symbols adapted from [] Cui and Xie, 2017; Molecules).'
papertitle: Tumor-Suppressor Role of the α1-Na/K-ATPase Signalosome in NASH Related
  Hepatocellular Carcinoma .
reftext: Utibe-Abasi S. Udoh, et al. Int J Mol Sci. 2022 Jul;23(13):7359.
year: '2022'
doi: 10.3390/ijms23137359
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords: hepatocellular carcinoma | non-alcoholic steatohepatitis | α1-Na/K-ATPase
  | PI3K → Akt Pathway | FoxO3 signaling | pNaKtide
automl_pathway: 0.6806982
figid_alias: PMC9266688__F8
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC9266688__F8
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9266688__ijms-23-07359-g008.html
  '@type': Dataset
  description: 'Proposed schematic diagram of activated α1-NKA Signalosome mediated
    NASH-related HCC malignancy. At the onset of NAFLD, the signalosome is inactive
    but as NAFLD progresses there is generation of ROI, resulting in the activation
    of the signalosome and induction of NASH. Continuous activation of the signalosome
    by ROI, coupled with the underlying NASH microenvironment results in the amplification
    of ROI production via the EGFR-Ras/Raf/MEK/ERK cascade, turning into a vicious
    cycle that intensifies the activation of the α1-NKA/Src signalosome which concludes
    in genesis of liver malignancy by survivin overexpression. Survivin induces carcinogenesis
    by inhibiting apoptosis, and heightening cell proliferation and tumor angiogenesis.
    The chart also displays certain proteins and metabolic and morphological disarray
    that drive activated α1-NKA signalosome-mediated hepatocarcinogenesis. (Note:
    EGFR, Ras/Raf/MEK/ERK pathway symbols adapted from [] Cui and Xie, 2017; Molecules).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Atpalpha
  - Col4a1
  - Ca-alpha1D
  - alphaTub84B
  - nAChRalpha1
  - wb
  - Prosalpha1
  - pnt
  - bs
  - foxo
  - cx
  - frag
  - dbo
  - Src42A
  - Csk
  - Src64B
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - amos
  - Low
  - aa
  - Egfr
  - Akt
  - S6k
  - Mtor
  - Tor
  - ADRA1D
  - FOXO1
  - COL6A1
  - COL6A2
  - COL6A3
  - COL6A5
  - COL6A6
  - COL7A1
  - COL8A1
  - COL8A2
  - COL9A1
  - COL9A2
  - COL9A3
  - COL10A1
  - COL11A1
  - COL11A2
  - COL12A1
  - COL13A1
  - COL14A1
  - COL15A1
  - COL16A1
  - COL17A1
  - COL18A1
  - COL19A1
  - COL20A1
  - COL21A1
  - COL22A1
  - COL23A1
  - COL24A1
  - COL25A1
  - COL26A1
  - COL27A1
  - COL28A1
  - COL1A1
  - COL1A2
  - COL4A1
  - COL4A2
  - COL4A3
  - COL4A4
  - COL4A5
  - COL4A6
  - COL5A1
  - COL5A2
  - COL5A3
  - DIABLO
  - SRC
  - FGR
  - FYN
  - YES1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - EGFR
  - AKT1
  - AKT2
  - AKT3
  - RPS6KB1
  - MTOR
---
